Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, 710-8602, Japan.
Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):91-98. doi: 10.1007/s10096-017-3105-6. Epub 2017 Sep 17.
Chronic pulmonary aspergillosis (CPA) is associated with mortality in patients with Mycobacterium avium complex lung disease (MAC-LD). An Aspergillus-positive respiratory specimen often reflects colonization, and thus the clinical significance of Aspergillus isolation in MAC-LD patients is not well understood. The objective of this study was to investigate the clinical characteristics and outcomes of MAC-LD patients in whom Aspergillus was isolated from respiratory specimens. We performed a retrospective review of the medical records of 329 MAC-LD patients. We compared the characteristics and mortality rates between patients with Aspergillus isolation and those without. All Aspergillus species detected from respiratory specimens within the follow-up period were reviewed. Aspergillus was detected in 40 (12.2%) of the 329 patients. There were no significant differences in the clinical characteristics and mortality rates between patients with and without Aspergillus isolation. Among the 40 patients with Aspergillus isolation, 9 (22.5%) developed CPA. CPA was most often caused by A. fumigatus. In the 40 Aspergillus-positive patients, patients with A. fumigatus isolation had a significantly higher mortality rate than those without (P < 0.001). The multivariate Cox proportional hazards model showed older age (P = 0.050), presence of respiratory comorbidities (P = 0.008), hypoalbuminemia (P < 0.001), and isolation of A. fumigatus (P = 0.005) to be prognostic factors for mortality in MAC-LD patients. There was no significant difference in the mortality rates between patients with Aspergillus isolation and those without. However, isolation of A. fumigatus may be associated with poor prognosis in MAC-LD patients.
慢性肺曲霉病(CPA)与分枝杆菌复合群肺病(MAC-LD)患者的死亡率相关。曲霉阳性呼吸道标本通常反映定植,因此 MAC-LD 患者中曲霉分离的临床意义尚不清楚。本研究旨在探讨从呼吸道标本中分离出曲霉的 MAC-LD 患者的临床特征和结局。我们对 329 例 MAC-LD 患者的病历进行了回顾性分析。我们比较了有和没有曲霉分离的患者的特征和死亡率。在随访期间从呼吸道标本中检测到的所有曲霉种都进行了回顾。在 329 例患者中,有 40 例(12.2%)检测到曲霉。有和没有曲霉分离的患者在临床特征和死亡率方面没有显著差异。在 40 例曲霉分离的患者中,有 9 例(22.5%)发生 CPA。CPA 最常由烟曲霉引起。在 40 例曲霉阳性患者中,分离出烟曲霉的患者死亡率明显高于未分离出烟曲霉的患者(P<0.001)。多变量 Cox 比例风险模型显示,年龄较大(P=0.050)、存在呼吸合并症(P=0.008)、低白蛋白血症(P<0.001)和分离出烟曲霉(P=0.005)是 MAC-LD 患者死亡的预后因素。有和没有曲霉分离的患者的死亡率没有显著差异。然而,烟曲霉的分离可能与 MAC-LD 患者的不良预后有关。